参考文献/References:
1 King AD,Yeung DK,Ahuj a AT.In vivo 1H MR spectroscopy of thyroid carcinoma.Eur J Radiol,2005,54(1):112-117.
2 Moka D,Dietlein M,Raffelt K,et al.Differentiation between healthy thyroid remnants and tumor tissue after radioiodine therapy in patients with differentiated thyroid carcinoma using in vitro phosphorus-31 magnetic resonance spectroscopy.Am J Med,2002,112(8):634-641.
3 Rosario PW,de Faria S,Bicalho L,et al.Ultrasonographic differentiation between metastatic and benign lymph nodes in patients with papillary thyroid carcinoma.J Ultrasound Med,2005,24(10):1385-1189.
4 Spiezia S,Farina R,Cerbone G,et al.Analysis of color Doppler signal intensity variation after levovist injection:a new approach to the diagnosis of thyroid nodules.J Ultrasound Med,2001,20(3):223-231.
5 Argalia G,De Bemardis S,Mariani D,et al.Ultrasonographic contrast agent:evaluation of time-intensity curves in the characterisation of solitary thyroid nodules.Radiol Med(Torino),2002,103(4):407-413.
6 Tollin SR,Mery GM,Jelveh N,et al.The use of fine-needle aaspiration biopsy under ultrasound guidance to assess the risk of malignancy in patients with a multinodular goiter.Thyroid,2000,10(3):235-241.
7 Elio R,Roberta R,Giorgio T,et al.Clinical and histological characteristics of papillary thyroid microcarcinoma:Results of a retrospective study in 243 patients.J Clin Endocrin Metab,2006,91(6):2171-2178.
8 Frates MC,Benson CB,Charboneau JW,et al.Management of thyroid nodules detected at US:Society of radiologists in ultrasound consensus conference statement.Radiology,2005,237(3):794-800.
9 Lyshchik A,Higashi T,Asato R,et al.Thyroid gland tumor diagnosis at US elastography.Radiology,2005,237(1):202-211.
10 Hatipoglu BA,Gierlowski T,Shore-Freedman E,et al.Fine-needle aspiration of thyroid nodules in radiation-exposed patients.Thyroid,2000,10(1):63-69.
11 Fujie S,Okumura Y,Sato S,et al.Diagnostic capabilities of I-131,Tl-201,and Tc-99m-MIBI scintigraphy for metastatic differentiated thyroid carcinoma after total thyroidectomy.Acta Med Okayama,2005,59(3):99-107.
12 Arslan N,Ilgan S,Yuksel D,et al.Comparison of In-111 octreotide and Tc-99m (V) DMSA scintigraphy in the detection of medullary thyroid tumor foci in patients with elevated levels of tumor markers after surgery.Clin Nucl Med,2001,26(8):683-688.
13 Giammarile F,Houzard C,Bournaud C,et al.Diagnostic management of suspected metastatic thyroid carcinoma:clinical value of octreotide scintigraphy in patients with negative high-dose radioiodine Scans.Eur J Endocrinol,2004,150(3):277-283.
14 Pacini F,Agate L,Elisei R.Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic 131I whole body scan:Comparison of patients treated with high 131I activities versus untreated patients.J Clin endocrinol Metab,2001,86(9):4092-4097.
15 Helal BO,Merlet P,Toubert ME,et al.Clinical impact of 18F-FD GPET in thyroid carcinoma patients with elevated thyroglo-bulin levels and negative 131I scanning results after therapy.J Nucl Med,2001,42(10):1464-1469.
16 Wang WP,Larson SM,Fazzari M,et al.Prognostic value of (18F) fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer.J Clin Endocrinol Metab,2000,85(3):1107-1113.
17 Petrich T,Borner AR,Otto D,et al.Influence of rhTSH on[18F] fluorodeoxyglucose uptake by differentiated thyroid carcinoma.Eur J Nucl Med Mol Imaging,2002,29(5):641-647.
18 Ishigaki S,Shimamoto K,Satake H,et al.Multi-slice CT of thyroid nodules:comparison with ultrasonography.Radiat Med,2004,22(5):346-353.
19 Ruf J,Lehmkuhl L,Bertram H,et al.Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma.Nucl Med Commun,2004,25(12):1177-1182.
20 de Groot JW,Links TP,Jager PL,et al.Impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer.Ann Surg Oncol,2004,11(8):786-794.
相似文献/References:
[1]周玉祥,蓝博文,黄春榆,等.64排螺旋CT冠状动脉血管成像诊断冠状动脉-肺动脉瘘的应用价值[J].国际放射医学核医学杂志,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
Zhou Yuxiang,Lan Bowen,Huang Chunyu,et al.Clinical value of coronary artery-pulmonary artery fistula revealed by 64-slice spiral CT coronary angiography[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
[2]陈超坤,刘亮,傅飞先,等.囊性胸腺瘤和囊性畸胎瘤的影像学特征及鉴别诊断[J].国际放射医学核医学杂志,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
Chen Chaokun,Liu Liang,Fu Feixian,et al.Imaging features and differential diagnosis of cystic thymoma and cystic teratoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
[3]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[4]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[5]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[6]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[7]周翠屏,廖俊杰,何国华,等.原发性肠系膜巨大淋巴结增生症的MSCT表现与病理对照分析[J].国际放射医学核医学杂志,2016,40(3):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
Zhou Cuiping,Liao Junjie,He Guohua,et al.Primary mesenteric Castleman disease:MSCT findings with histopathologic correlation[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
[8]李盼丽,宋少莉.碘难治性分化型甲状腺癌靶向药物治疗进展[J].国际放射医学核医学杂志,2016,40(3):202.[doi:10.3760/cma.j.issn.1673-4114.2016.03.009]
Li Panli,Song Shaoli.Radioactive iodine refractory differentiated thyroid cancer targeted therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):202.[doi:10.3760/cma.j.issn.1673-4114.2016.03.009]
[9]张巧娜,刘汉东.上颌窦上皮-肌上皮癌的CT表现一例[J].国际放射医学核医学杂志,2016,40(3):237.[doi:10.3760/cma.j.issn.1673-4114.2016.03.015]
[10]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[11]陈立,陈跃.分化型甲状腺癌骨转移诊断及疗效评价的核素显像研究进展[J].国际放射医学核医学杂志,2016,40(6):452.[doi:10.3760/cma.j.issn.1673-4114.2016.06.010]
Chen Li,Chen Yue.Diagnosis and evaluation of curative effect progress of radionuclide imaging methods in differentiated thyroid cancer of bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):452.[doi:10.3760/cma.j.issn.1673-4114.2016.06.010]
[12]胡斌,王锦锋,毛秋粉.18F-FDG PET/CT显像在Tg阳性131I全身显像阴性的分化型甲状腺癌患者中的应用价值[J].国际放射医学核医学杂志,2015,39(3):242.[doi:10.3760/cma.j.issn.1673-4114.2015.03.012]
Hu Bin,Wang Jinfeng,Mao Qiufen.The application value of 18F-FDG PET/CT in patients with differentiated thyroid cancer of high thyroglobulin level and negative 131I whole body scan[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):242.[doi:10.3760/cma.j.issn.1673-4114.2015.03.012]
[13]汤敏敏,刘建中,武志芳,等.分化型甲状腺癌患者131I治疗后体内残留放射性活度的评估[J].国际放射医学核医学杂志,2014,38(6):363.[doi:10.3760/cma.j.issn.1673-4114.2014.06.004]
Tang Min-min,Liu Jian-zhong,Wu Zhi-fang,et al.Estimation of residual activities in patients with differentiated thyroid cancer after administration of 131I for therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):363.[doi:10.3760/cma.j.issn.1673-4114.2014.06.004]
[14]常伟,高再荣.甲状腺癌分子影像诊断与靶向治疗研究进展[J].国际放射医学核医学杂志,2009,33(4):218.[doi:10.3760/cma.j.issn.1673-4114.2009.04.008]
CHANG Wei,GAO Zai-rong.Advances on molecular imaging diagnosis and targeted therapy of thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(5):218.[doi:10.3760/cma.j.issn.1673-4114.2009.04.008]
[15]咸雨蔚,左书耀.甲状腺肿瘤SPECT-CT融合显像的应用近况[J].国际放射医学核医学杂志,2006,30(3):157.
XIAN Yu-wei,ZUO Shu-yao.Fusion images of SPECT-CT in the application of thyroid neoplasms[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(5):157.